Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) is now available.
ResMed Inc’s Global General Counsel, Michael J. Rider, reported a transaction involving the disposal of 100 shares of ResMed common stock on October 1, 2025, at a price of $274.36 per share. This transaction was conducted under a pre-established Rule 10b5-1 trading plan, which allows company insiders to sell stocks at predetermined times to avoid accusations of insider trading. The transaction reflects a strategic financial decision by the company’s executive, potentially impacting the perception of the company’s stock value among stakeholders.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$48.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc operates in the healthcare industry, focusing on the development and manufacturing of products related to sleep disorders, respiratory care, and connected health solutions. The company is known for its innovative devices and software applications that help diagnose, treat, and manage sleep apnea and other chronic respiratory conditions.
Average Trading Volume: 1,049,105
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$62.56B
For an in-depth examination of RMD stock, go to TipRanks’ Overview page.